Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06343246
Other study ID # MustafaKemalU
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 1, 2023
Est. completion date March 30, 2024

Study information

Verified date March 2024
Source Mustafa Kemal University
Contact Irem Hüzmeli, PhD
Phone +903262455516
Email fztirem@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was planned to investigate the effectiveness of combined exercise training, that is, functional inspiratory muscle training, with breathing exercises to be applied with a portable, easy-to-use respiratory muscle strengthening device, on exercise capacity and peripheral muscle strength.


Description:

Forty-five Individuals will be randomly divided into three groups: Functional IMT Group (n:15): will receive functional inspiratory muscle training (exercise + 50% of MIP) IMT Group I (n:15): will recieve inspiratory muscle training (50% of MIP ) Control group (n:15): will recieve breathing exercises training


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date March 30, 2024
Est. primary completion date March 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Systolic blood pressure =140 mmHg or diastolic blood pressure =90 mmHg, 2. It will include both male and female subjects aged =18 and <80 years with a previous diagnosis of essential hypertension. 3. Subjects receiving no pharmacological treatment or receiving only thiazide diuretics 4. Those with a body mass index <30 kg/m2 Those who engage in <150 minutes of moderate or intense physical activity per week, according to the 5th International Physical Activity Survey Exclusion Criteria: 1. Blood pressure =160 / 100 mmHg 2. Severe dyspnea; diabetes; orthopedic, musculoskeletal, or fitness limitations; 3. Major physiological crises; 4. A current or past history of deep venous thrombosis; History of myocardial infarction or stroke within the 5th year or 6 months ago; 6. Congestive heart therapy; 7. Unstable angina; 8. or lung disease of any etiology (including asthma and chronic obstructive pulmonary disease); 9. Active smokers 10. Patients under 18 years of age 11. Pregnant women 12. Those with Active Infection 13. Those with Known Malignancy

Study Design


Intervention

Device:
Inspiratory muscle training with device
: A randomized, controlled three-arm study. Forty-five patients with HT randomized three group: Group 1 will receive IMT (7 days/8 weeks) with function and POWERbreathe® Classic LR device, group 2 will reviece only IMT with 50 % maximal inspiratory pressure (MIP), n: 15) and control group will recieve breathing exercises(7 days/8 weeks).

Locations

Country Name City State
Turkey Hatay Mustafa Kemal University Hatay Antakya

Sponsors (1)

Lead Sponsor Collaborator
Mustafa Kemal University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of the exercise capacity from baseline to 8 week Exercise capacity was evaluated with the 6-Minute Walk Test (6MWT). ATS (American Thoracic Society) criteria were taken into consideration and the subjects rested for at least half an hour before starting the test. Participants walked briskly at their own walking pace for 6 minutes on a 30-meter straight corridor. The distance reached at the end of the test was recorded in meters. from baseline to 8 week
Primary Change of the peripheral muscle strenght from baseline to 8 week Peripheral muscle strength and hand grip strength were evaluated with a portable dynamometer and the values obtained were recorded in Newton (N)/kgF/Pascal. Peripheral muscle strength was measured seated, employing a hand-held dynamometer (JTECH Power Track Commander, Baltimore, MD, USA). This device, known for its portability and cost-effectiveness, serves as an alternative to isokinetic machines and offers greater sensitivity in detecting changes in muscle strength compared to manual muscle tests.
Respiratory muscle strength 'maximum inspiratory pressure (MIP) and expiratory pressure (MEP)' will calculate with a portable, electronic mouth pressure measuring device.
from baseline to 8 week
Primary change of the upper extremity exercise capacity from baseline to 8 week 6PBRT is a test used to evaluate unsupported upper extremity exercise capacity. Participants will be asked to sit in an adjustable-height chair. The pegboard will be placed within arm's reach of the person. Participants will be asked to attach a total of 20 rings, 32 rings, 10 on each iron rod, located at both shoulder levels, to the iron rods 20 centimeters above, as quickly as possible, using both arms simultaneously, for six minutes, and then to attach and remove them again to the iron rods below. from baseline to 8 week
Secondary change of the postural balance from baseline to 8 week Timed Up and Go test (TUG): It measures the time it takes for the patient to get up from the chair, walk 3 m, turn around and sit down in the same chair again. The TUG test is a simple test used to evaluate postural mobility from baseline to 8 week
Secondary change of the physical activity from baseline to 8 week Physical activity level was measured with the International Physical Activity Questionnaire (IPAQ). In this questionnaire, which provides information about the time spent in sitting, walking, moderately vigorous activities, and vigorous activities, the criterion for evaluating all activities is that each activity is performed for at least 10 minutes at a time. from baseline to 8 week
Secondary change of the quality of life from baseline to 8 week SF-36 survey. In this scale, where health is examined in eight components, higher scores indicate a better level of health. SF-36 scale; physical functionality (limitation in physical activity due to health problems), physical role limitation in daily living activities due to health problems), bodily pain, general health (evaluation of the person's general health), vitality , general mental health, social functionality and emotional role (limitation in daily living activities due to mental health problems). The SF-36 scale is scored out of 100 points, and the scores vary between 0 and 100 points for each component. from baseline to 8 week
Secondary change of the Fev1/Fvc Pulmonary function test will measure with a portable spirometer (SPIROBANK IIĀ® Moggiolino, Rome-Italy). The best of 3 technically acceptable maneuvers with 95% agreement will select and record from baseline to 8 week
See also
  Status Clinical Trial Phase
Recruiting NCT05546931 - Mobile Health Program for Rural Hypertension N/A
Completed NCT05086549 - An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria
Recruiting NCT05086523 - Cardiac Neuromodulation Therapy (CNT) "Washout" Sub-Study Phase 1/Phase 2
Active, not recruiting NCT03503773 - The TARGET BP OFF-MED Trial Phase 2
Not yet recruiting NCT04082091 - Screening, Early Referral and Lifestyle Tailored E_prescription for Cardiovascular Prevention
Recruiting NCT06019598 - Licorice and Home Blood Pressure, Additional Study N/A
Completed NCT04495231 - Sympathetic Activity and Cardiometabolic Complications
Completed NCT04119999 - A Cardiosleep Research Program on Obstructive Sleep Apnea, Blood Pressure Control and Maladaptive Myocardial Remodeling N/A
Recruiting NCT04505618 - Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease N/A
Recruiting NCT04863508 - Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
Completed NCT05185297 - Recreational Futsal for Controlled Hypertension N/A
Completed NCT03855605 - Diagnosis of Hypertension by Home Blood Pressure Monitoring
Completed NCT03901183 - Plant-based Nutrition for Patients With Cardiovascular Risk Factors N/A
Recruiting NCT06348576 - Phase III Study to Evaluate the Efficacy and Safety of AD-209 Phase 3
Recruiting NCT03206814 - Improving Hypertension Control in CHina and ARGEntina With a Mobile APP-based Telecare System N/A
Completed NCT06359873 - Left Atrial Enlargement: A Crucial Indicator for Identifying Atrial Fibrillation in Patients With Hypertension
Recruiting NCT04565548 - Hypertension Treatment Adherence Improving Trial N/A
Recruiting NCT06205628 - Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension Phase 1
Recruiting NCT04613193 - Blood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis N/A
Completed NCT03841383 - Association Between Coronary Flow Reserve and BH4 Levels in High CV Risk